Manulife (Manufacturers Life Insurance)
ALXO icon

Manulife (Manufacturers Life Insurance)’s ALX Oncology ALXO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,662
Closed -$82.4K – 2998
2024
Q2 		$82.4K Sell
13,662
-46,457
-77% -$571K ﹤0.01% 2873
2024
Q1 		$670K Buy
60,119
+12,060
+25% +$169K ﹤0.01% 2067
2023
Q4 		$716K Buy
+48,059
New +$456K ﹤0.01% 2001
2022
Q1 		– Sell
-9,857
Closed -$212 – 3071
2021
Q4 		$212 Buy
9,857
+519
+6% +$22.4K ﹤0.01% 2853
2021
Q3 		$690K Sell
9,338
-817
-8% -$54.5K ﹤0.01% 2063
2021
Q2 		$555K Buy
10,155
+319
+3% +$19.1K ﹤0.01% 2359
2021
Q1 		$725K Buy
9,836
+3,995
+68% +$314K ﹤0.01% 2061
2020
Q4 		$503K Buy
+5,841
New +$351K ﹤0.01% 2188

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ALXO Position: Q3 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 13,662 shares — an estimated $82.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ALXO in Q4 2020 and held it in 8 quarters. The position peaked at $725K in Q1 2021. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 13,662 ALX Oncology shares in Q3 2024, an estimated $82.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in ALX Oncology in Q4 2020 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s ALX Oncology position peaked at $725K in Q1 2021.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2024, filed 13 Nov 2024.